(Q85176863)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20935681%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Preferences of patients and physicians concerning treatment options for relapsed follicular lymphoma: a discrete choice experiment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20935681%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

M Shafey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20935681%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

S M Lupichuk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20935681%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

T Do

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20935681%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

C Owen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20935681%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

D A Stewart

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20935681%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

11 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20935681%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

15 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20935681%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20935681%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20935681%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

962-969

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20935681%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2010.225

15 February 2020

exact match

0 references

cites work

New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

The natural history of initially untreated low-grade non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

Low-grade non-Hodgkin's lymphoma--development of a new effective combination regimen (fludarabine, mitoxantrone and dexamethasone; FND).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20+ B-cell lymphoma: long-term follow-up of a phase 1/2 study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

Yttrium-90 (90Y) ibritumomab tiuxetan (Zevalin) induces long-term durable responses in patients with relapsed or refractory B-Cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

Discrete choice experiments in health care

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

Eliciting public preferences for healthcare: a systematic review of techniques.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

Conducting discrete choice experiments to inform healthcare decision making: a user's guide.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

Deleting ‘irrational’ responses from discrete choice experiments: a case of investigating or imposing preferences?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

What influences clinicians’ operative preferences for women with breast cancer? An application of the discrete choice experiment

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

Discrete-choice experiment to measure patient preferences for the surgical management of colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

Patients' preferences for the management of non-metastatic prostate cancer: discrete choice experiment

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

Decision making heuristics and the elicitation of preferences: being fast and frugal about the future

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

A 15-Year Analysis of Early and Late Autologous Hematopoietic Stem Cell Transplant in Relapsed, Aggressive, Transformed, and Nontransformed Follicular Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021

Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.225

7 January 2021